*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>ETC-1002</strong> is an investigational small-molecule inhibitor targeting the endothelin pathway, primarily developed for oncology and cardiovascular disorders. Its synthesis involves complex organic coupling reactions to achieve high purity. Molecular formula: C<sub>24</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub>; CAS No.: Not publicly assigned.</p>
<h3>Application</h3>
<ul>
<li>Preclinical research in solid tumor models.</li>
<li>Vascular dysfunction studies in hypertension.</li>
<li>Drug discovery screening for endothelin receptor antagonists.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for laboratory use only; not approved for clinical therapy. Store under inert atmosphere at -20°C. Handle with PPE due to potential toxicity.</p>